Arthrosamid
What is Arthrosamid?
- Based on an innovative non-biodegradable hydrogel technology, Arthrosamid® is 2.5% cross-linked polyacrylamide and 97.5% water.
- The medical description of Arthrosamid® is an 'injectable polyacrylamide hydrogel' or '2.5% iPAAG'.
- Approved for the treatment of knee osteoarthritis, Arthrosamid® is suitable, safe and effective for most patients with the condition.
- Arthrosamid® is the first and only approved injectable treatment that permanently combines with the knee’s synovial tissue decreasing joint stiffness, diminishing pain, improving the function of the knee, and enhancing your quality of life.
Arthrosamid® is a permanent injectable hydrogel that delivers long-lasting, proven pain relief without surgery redefining treatment for knee osteoarthritis.
Proven
Supported by more than two decades of research, Arthrosamid® is proven to be safe and effective offering you long-lasting pain relief for your knee osteoarthritis.
Long-lasting
Arthrosamid® is proven to maintain a significant, long-lasting reduction in knee osteoarthritis pain even five years post-treatment.
Without surgery
Arthrosamid® is a simple, one-step procedure performed under local anaesthesia by a qualified physician without surgery.
How does Arthrosamid® (iPAAG) work?
- Arthrosamid® combines with the tissue lining your knee joint, thickening it to provide a barrier reducing your pain.
- Arthrosamid® permanently combines with the tissue lining your knee joint and it’s this unique characteristic that provides a significant reduction in your osteoarthritis pain over a longer period with one single treatment.
Safe & Effective
Arthrosamid® remains safe and effective for its intended use 5 years after treatment.
Close to 80% Response rate
Patients in the under 70 years group reported close to 80% positive response rate following treatment with Arthrosamid®.
Pain Reduction
In all our studies Arthrosamid® exceeds the MCID of points and improvement is maintained up to 5 years after a single injection.
In all our studies
Arthrosamid® exceeds the MCID of points and improvement is maintained up to 5 years after a single injection.
Responder rates by age
Patients in the under 70 years group reported close to 80% positive response rate following treatment with Arthrosamid®.